ELIRAN MOR

Please submit tables as editable text and not as images. Tables should be placed at the end of the manuscript file, following the figure legends or reference list. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules.

Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article. This can be done in the

same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the file in one of our recommended file formats with a preferred maximum size of 150 MB per file, 1 GB in total. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.

Elsevier accepts electronic supplemental material to support and enhance your scientific research. Supplemental files offer the author additional possibilities to publish supporting applications, high- resolution images, background datasets, sound clips, and more. Supplemental files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect. In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at https://www.elsevier.com/artworkinstructions.

This journal encourages you to share data that supports your research publication in an appropriate data repository, and enables you to interlink the data with your published articles. If you are sharing data, you are encouraged to cite the data in your manuscript and reference list. Please refer to the ""References"" section for more information about data citation.

Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project.

If you have made your research data available in a data repository, you can link your article directly to the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with relevant repositories, giving readers access to underlying data that gives them a better understanding of the research described.

There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. For more information, visit the database linking page.

This journal supports Mendeley Data, enabling you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository. Before submitting your article, you can deposit the relevant datasets to Mendeley Data. Please include the DOI of the deposited dataset(s) in your main manuscript file. The datasets will be listed and directly accessible to readers next to your published article online.

To ensure a fast publication process of the article, we kindly ask authors to provide us with their proof corrections within two days. Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online.

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

Draws on 130 interviews---with scientists, clinicians, and women who have either donated or frozen their oocytes or received those of another woman---to trace how the history of human oocytes' perceived value intersects with the biological and social life of women.

Drawing on theories and concepts across medical sociology and parenting culture studies, as well as literature from demography, anthropology, law, and bioethics, this book examines women's motivations and experiences of social egg freezing in the context of debates surrounding reproductive choice and delayed motherhood.

Presents the first holistic analysis of PGD and PGS as it is practiced and regulated worldwide. In addition to scientific and technical aspects, the book provides perspectives on the ethical, legal, religious, policy and social implications of global assisted reproduction technologies.

This tells the story of doctors, researchers, and hopeful couples who pushed the limits of science and triggered a technological revolution in human reproduction. In so doing, they landed at the center of a controversy whose reverberations continue to this day.

In the United States, some 10% of people who wish to have children struggle with infertility. NOVA explores barriers to fertility, from the social to the biological, and the state of assisted reproductive technologies. Follow the journeys of people navigating challenges from structural inequalities and racism to falling sperm counts, egg freezing, and IVF.

To examine the psychological impact of fertility treatment suspensions resulting from the COVID-19 pandemic and to clarify psychosocial predictors of better or worse mental health. 92 women from Canada and the United States (ages 20-45 years) whose fertility treatments had been cancelled were recruited via social media. Participants completed a battery of questionnaires assessing depressive symptoms, perceived mental health impact, and change in quality of life related to treatment suspensions. Potential predictors of psychological outcomes were also examined, including several personality traits, aspects of social support, illness cognitions, and coping strategies.

Eliran Mor

Infertility is a condition that affects nearly 30 percent of women aged 25–44 in the United States. Though past research has addressed the stigmatization of infertility, few have done so in the context of stigma management between fertile and infertile women. In order to assess evidence of felt and enacted stigma, we employed a thematic content analysis of felt and enacted stigma in an online infertility forum, Fertile Thoughts, to analyze 432 initial threads by women in various stages of the treatment-seeking process.

In an effort to place the recent Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report publications regarding conception options for mixed-status couples with human immunodeficiency virus (HIV) in perspective, the researchers review the historical evolution of conception options for mixed-status couples with HIV with particular focus on the potential need for fertility treatment and the feasibility of accessing such treatment.

Are you trying to get pregnant? You might wonder whether there's anything you can do to make it easier to conceive. Some things might be beyond your control or need medical help. These include medical issues that affect being able to conceive. But your lifestyle choices can affect fertility too. Here's what you need to know.

Female fertility is being able to get pregnant. Have you and your partner been trying to get pregnant by having sex without birth control for at least one year with no success? Not getting pregnant in that time might make you wonder how fertile you are. Anyone can be affected by fertility concerns or problems.

Trouble releasing eggs, called ovulating, or trouble with regular periods. Hormone-related conditions can affect the release of eggs from the ovaries. These conditions include polycystic ovary syndrome, high prolactin hormone levels and thyroid conditions. Other conditions that may change ovulation or periods are poorly controlled diabetes and some autoimmune diseases such as lupus.

Aging. Waiting to try to get pregnant can lower the chance of being able to conceive. As you move closer to your 40s, you lose eggs at a faster rate. And the eggs you have are less likely to become fertile.

Try not to work the night shift. Working the night shift all the time might affect your hormone levels. This can raise the risk of not being fertile. If you do work the night shift, try to get enough sleep when you're not working.

Stress isn't likely to keep you from getting pregnant. But stress isn't good for your health. Think about ways to lower stress. Try meditation, deep breathing, yoga or other activities to lower and manage stress when you try to conceive.

Limit or avoid alcohol when trying to conceive. Heavy drinking is linked with an higher risk of problems ovulating. To help when you're trying to get pregnant, stop drinking alcohol. Not drinking is the best choice when you conceive and during pregnancy.

Don't exercise too hard or too long. For people at a healthy weight, too much hard exercise can affect ovulating and lower levels of the hormone progesterone. If you want to become pregnant soon, think about limiting hard exercise, such as running or fast cycling, to less than five hours a week and less than 60 minutes a day.

Avoid toxins. There are many toxins in the environment. These include pesticides, dry-cleaning solvents and lead. They can harm fertility. Be aware of these toxins and discuss ways to limit exposure to them with a member of your healthcare team.

STUDY QUESTION Is there evidence of a plateau in the cumulative live birth rate (cLBR) after a certain number of consecutive transfers of untested embryos? SUMMARY ANSWER In our cohort of 11 463 women, the cLBR continues to increase with each additional transfer of an untested embryo, reaching 68.3% after six blastocyst ...

STUDY QUESTION Can a video clip detailing the patient journey decrease women’s anxiety on the day of their first oocyte retrieval? SUMMARY ANSWER The video clip does not affect women’s anxiety on the day of their first oocyte retrieval. WHAT IS KNOWN ALREADY IVF triggers anxious reactions in women and men, with peaks of ...

STUDY QUESTION Do serum estradiol (E2) levels on the day of frozen blastocyst transfer (FBT) affect pregnancy outcomes in hormonal replacement therapy (HRT) cycles using transdermal estrogens? SUMMARY ANSWER E2 levels ≥313 pg/ml on the day of FBT are associated with increased early miscarriage rates (EMRs), but do not ...

STUDY QUESTION Is semen quality associated with the lifespan of men? SUMMARY ANSWER Men with a total motile sperm count of >120 million could expect to live 2.7 years longer than men with total motile sperm count of >0–5 million. WHAT IS KNOWN ALREADY Male infertility and semen quality have been suggested to be ...

STUDY QUESTION Does the intravenous administration of Atosiban around the time of frozen blastocyst transfer to reduce uterine contractility increase the likelihood of live birth in individuals undergoing ART treatment? SUMMARY ANSWER In individuals with a history of one previous implantation failure, Atosiban did not ...